2-amino-6-chloropyrazine - CAS 33332-28-4
Catalog: |
BB021669 |
Product Name: |
2-amino-6-chloropyrazine |
CAS: |
33332-28-4 |
Synonyms: |
6-chloro-2-pyrazinamine; 6-chloropyrazin-2-amine |
IUPAC Name: | 6-chloropyrazin-2-amine |
Description: | 2-amino-6-chloropyrazine (CAS# 33332-28-4) is a disubstituted pyrazine used in the preparation of A2B adenosine receptor antagonists and other biologically active compounds. |
Molecular Weight: | 129.55 |
Molecular Formula: | C4H4ClN3 |
Canonical SMILES: | C1=C(N=C(C=N1)Cl)N |
InChI: | InChI=1S/C4H4ClN3/c5-3-1-7-2-4(6)8-3/h1-2H,(H2,6,8) |
InChI Key: | JTPXVCKCLBROOJ-UHFFFAOYSA-N |
Boiling Point: | 282.8 °C at 760 mmHg |
Purity: | 97.0 % |
Density: | 1.437 g/cm3 |
MDL: | MFCD00055024 |
LogP: | 1.29340 |
GHS Hazard Statement: | H302 (90.48%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-112341437-A | Substituted pyrazine derivative and application thereof | 20201221 |
CN-112409337-A | Substituted pyrazine derivative and application thereof | 20201221 |
WO-2021202977-A1 | Pyrrolopyrimidine amines as complement inhibitors | 20200403 |
CN-111217760-A | Synthetic method of sulfachloropyrazine sodium | 20200327 |
WO-2021097054-A1 | 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity | 20191112 |
PMID | Publication Date | Title | Journal |
22111927 | 20111222 | Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing | Journal of medicinal chemistry |
18656911 | 20080828 | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design | Journal of medicinal chemistry |
15658854 | 20050127 | Fragment-based lead discovery using X-ray crystallography | Journal of medicinal chemistry |
Complexity: | 77.7 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 129.0093748 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 129.0093748 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 51.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS